摘要
目的观察喘可治注射液治疗支气管哮喘的临床疗效。方法选择我院2007年6月-2009年12月确诊为支气管哮喘患者98例，随机分为2组：治疗组50例，在常规治疗的基础上，加用喘可治注射液；对照组48例，仅给予常规治疗。2组在治疗过程中如合并呼吸道细菌感染，加用抗生素。有哮喘急性发作，可加用B2受体激动剂。观察2组治疗前后夜间憋醒次数、哮喘急性发作的次数、B2受体激动剂应用次数及肺功能情况。结果治疗组总有效率为96％，对照组总有效率为81．25％。2组比较差异有统计学意义（P〈0．05）。结论作为哮喘的补充治疗，喘可治注射液治疗效果满意。
Objective To observe the curative effect of Chuankezhi injection on bronchial asthma.Methods 98 patients with bronchial asthma diag＋msed in 2007-2009 were randomly selected and divided into 2groups.50 cases in the treatment group were treated with Chuankezhi injection on the basis of routine treatment,while 48 cases in the control group were treated with routine treatment.Then improvement of symptom and correlative indexes were observed before and after treatments.Results The tolal effective rate in the treatment group was 96%versus 81.25%in the cnntrnl grnup,and the difference was significant（P〈0.05）.Conclusion As a supplementary therapy of routine treatment,Chuankezhi injection has a better effect on bronchial asthma
关键词
支气管哮喘
喘可治
bronchial asthma
Chuankezhi
